• Pharmacology
  • Allergy, Immunology, and ENT
  • Cardiology
  • Emergency Medicine
  • Endocrinology
  • Adolescent Medicine
  • Gastroenterology
  • Infectious Diseases
  • Neurology
  • OB/GYN
  • Practice Improvement
  • Gynecology
  • Respiratory
  • Dermatology
  • Mental, Behavioral and Development Health
  • Oncology
  • Rheumatology
  • Sexual Health
  • Pain

Fish oil may mitigate cardiovascular risk of impaired fetal growth

Article

Daily fish oil supplementation during the first 5 years of life may reduce the risk of later cardiovascular disease in those with impaired fetal growth.

Daily fish oil supplementation during the first 5 years of life may reduce the risk of later cardiovascular (CV) disease in those with impaired fetal growth, researchers have found in a controlled clinical trial.

Babies with a birth weight below the 90th percentile for their gestational age and sex (n=363) were studied. They were randomized to a 500-mg fish oil supplement daily along with canola-based margarine and cooking oil (omega-3 group) or to a control group that received a sunflower oil supplement and omega-6 fatty acid-rich margarine and cooking oil.

Carotid intima-media thickness (IMT), a surrogate marker of subclinical atherosclerosis, was measured when the children were 8 years old.

Each 1-kg lower birth weight normally translates into a 10% to 20% increased risk of coronary artery disease in adulthood, but the omega-3 supplementation appeared to mitigate this increase in risk. The researchers note that the effect of omega-3 supplementation on carotid IMT is consistent with a potential 5% to 7% reduction in risk of future myocardial infarction and a 6% to 8% reduction in risk of future stroke per kilogram of birth weight.

Compliance with the fish oil capsules was only about 50%, so the true benefit of omega-3 supplementation may be even greater than that observed in this study, they add.

Skilton MR, Aver JG, Harmer JA, et al. Impaired fetal growth and arterial wall thickening: a randomized trial of omega-3 supplementation. Pediatrics. 2012. Epub ahead of print.

Related Videos
Venous thromboembolism, Heparin-induced thrombocytopenia, and direct oral anticoagulants | Image credit: Contemporary Pediatrics
Jessica Peck, DNP, APRN, CPNP-PC, CNE, CNL, FAANP, FAAN
Sally Humphrey, DNP, APRN, CPNP-PC | Image Credit: Contemporary Pediatrics
Ashley Gyura, DNP, CPNP-PC | Image Credit: Children's Minnesota
Congenital heart disease and associated genetic red flags
Traci Gonzales, MSN, APRN, CPNP-PC
Donna Hallas, PhD, CPNP, PPCNP-BC, PMHS, FAANP, FAAN
Scott Ceresnak, MD
© 2024 MJH Life Sciences

All rights reserved.